RDIF and LAXISAM agree to supply up to 35 million doses of Sputnik V vaccine to Uzbekistan
MOSCOW, Sept. 25, 2020 /PRNewswire/ — The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and LAXISAM, one of the leading pharmaceutical companies in the Republic of Uzbekistan, have agreed to supply to the country up to 35 million doses of the Sputnik V vaccine, which is based on a well-studied human adenoviral vectors platform […]